Clinical Trials Browser

Unknown × Lymphoma, Extranodal NK-T-Cell × pembrolizumab × Clear all

NCT03107962 2017-04-11

Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell